Tricyclic Neovibsanin Scaffold (TCNS) as an Effective Antidepressant Agent

Abstract

Neovibsanin type natural products were found to display neurite outgrowth activity in PC12 cells. This suggests that such type of compounds could be promising candidates for the development of novel therapeutic agents to treat neurological diseases. In the present study rats after chronic mild stress (CMS) were treated with tricyclic neovibsanin scaffold (TCNS) to study its effect on depression. The results revealed that 15 mg/kg doses of TCNS reduced the duration of immobility in CMS model of depression. It led to a significant increase in neurite outgrowths which increased the synaptic and structural plasticity of neurons. Treatment with TCNS decreased the levels of MAO-A and caspase-3 expression both of which were found to be higher in CMS. TCNS also led to an increase in expression of heat shock protein 70 (Hsp70) in the hippocampus. These findings suggest that TCNS possesses antidepressant activity in CMS model of depression. Therefore the relief in depression by TCNS may be due to suppression of MAO-A expression and the apoptosis cascade by increased expression of Hsp70.

Key words

neovibsanin scaffold - antidepressant activity - chronic mild stress - neurite outgrowth - neurotrophin

^* All the authors contributed equally to this work.

• References

• 1 Rajkowska G. Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits. Progress in Brain Research 2000; 126: 397-412
• 2 Cotter D, Mackay D, Landau S et al. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Archives of General Psychiatry 2001; 58: 545-553
• 3 Cotter D, Mackay D, Chana G et al. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex 2002; 12: 386-394
• 4 Campbell S, MacQueen G. An update on regional brain volume differences associated with mood disorders. Current Opinion in Psychiatry 2006; 19: 25-33
• 5 Duman RS. Pathophysiology of depression: the concept of synaptic plasticity. European Psychiatry 2002; 17: 306-310
• 6 Oliveira SL, Pillat MM, Cheffer A et al. Functions of neurotrophins and growth factors in neurogenesis and brain repair. Journal of the International Society for Advancement Cytometry 2013; 83: 76-89
• 7 Callaghan CK, Kelly AM. Neurotrophins play differential roles in short and long-term recognition memory. Neurobiology of Learning and Memory 2013; 104: 39-48
• 8 Jiang C, Salton SR. The role of neurotrophins in major depressive disorder. Translational Neuroscience 2013; 4: 46-58
• 9 Nemeroff CB. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res 2007; 41: 189-206
• 10 Rosen RC, Marin H. Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry 2003; 64 (Suppl 10): 5-10
• 11 Duman RS. Depression: a case of neuronal life and death?. Biol Psychiatry 2004; 56: 140-145
• 12 Kimmins S, MacRae TH. Maturation of steroid receptors: an example of functional cooperation among molecular chaperones and their associated proteins. Cell Stress Chaperones 2000; 5: 76-86
• 13 Rajapandi T, Greene LE, Eisenberg E. The molecular chaperones Hsp90 and Hsc70 are both necessary and sufficient to activate hormone binding by glucocorticoid receptor. J Biol Chem 2000; 275: 22597-22604
• 14 Martini F, Fernández C, Segundo LS et al. Assessment of potential immunotoxic effects caused by cypermethrin, fluoxetine, and thiabendazole using heat shock protein 70 and interleukin-1beta mRNA expression in the anuran Xenopus laevis. Environ Toxicol Chem 2010; 29: 2536-2543
• 15 Yu J, Roh S, Lee JS et al. The effects of venlafaxine and dexamethasone on the expression of HSP70 in rat C6 glioma cells. Psychiatry Investig 2010; 7: 43-48
• 16 Allagui MS, Nciri R, Rouhaud MF et al. Long-term exposure to low lithium concentrations stimulates proliferation, modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells. Neurochem Res 2009; 34: 453-462
• 17 Evans CG, Chang L, Gestwicki JE. Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem 2010; 53: 4585-4602
• 18 Parsell DA, Lindquist S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu Rev Genet 1993; 27: 437-496
• 19 Sharp FR, Massa SM, Swanson RA. Heat-shock protein protection. Trends Neurosci 1999; 22: 97-99
• 20 Ooie T, Takahashi N, Saikawa T et al. Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation 2001; 104: 1837-1843
• 21 Guo S, Wharton W, Moseley P et al. Heat shock protein 70 regulates cellular redox status by modulating glutathione-related enzyme activities. Cell Stress Chaperones 2007; 12: 245-254
• 22 Fukuyama Y, Minami H, Takeuchi K et al. Neovibsanines A and B, Unprecedented Diterpenes from Viburnum awabuki. Tetrahedron Lett 1996; 37: 6767- 6770
• 23 Fukuyama Y, Minami H, Yamamoto I et al. Chem Pharm Bull 1998; 46: 545 - (b) Kubo M, Minami H, Hayashi E, Kodama M, Kawazu K, Fukuyama Y. Tetrahedron Lett. 1999; 40: 6261- (c) Kubo M, Chen I-S, Fukuyama Y. Chem. Pharm. Bull. 2001; 49: 242- (d) Fukuyama Y, Kubo M, Minami H, Yuasa H, Matsuo A, Fujii T, Morisaki M, Harada K. Chem. Pharm. Bull. 2005; 53: 72- (e) Fukuyama Y, Fujii H, Minami H, Takahashi H, Kubo M. J. Nat. Prod. 2006; 69: 1098- (f) Fukuyama Y, Kubo M, Esumi T, Harada K, Hioki H. Heterocycles 2010; 81: 1571- (g) Fykuyama Y, Kubo M. Curr. Top. Phytochem. 2011; 10: 39-
• 24 Gallen MJ, Williams CM. Total Synthesis of (±)-5,14-bis-epi-Spirovibsanin A. Org Lett 2008; 10: 713-715 (b) Chen APJ, Williams CM. Total Synthesis of (±)-2-O-Methylneovibsanin H. Org. Lett. 2008; 10: 3441–3443
• 25 Imagawa H, Saijo H, Kurisaki T et al. Total Synthesis of (±)-Neovibsanin B. Org Lett 2009; 11: 1253-1255 (b) Esumi T, Mori T, Zhao M, Toyota M, Fukuyama Y. First Enantiocontrolled Formal Synthesis of (+)-Neovibsanin B, A Neurotrophic Diterpenoid. Org Lett 2010; 12: 888–891
• 26 Lone AM, Bhat BA, Mehta G. A general, flexible, ring closing metathesis (RCM) based strategy for accessing the fused furo[3,2-b]furanone moiety present in diverse bioactive natural products. Tetrahedron Lett. 2013; 54: 5619-5623
• 27 Steru L, Chermat R, Thierry B et al. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985; 85: 367-370
• 28 Yin C, Gou L, Liu Y et al. Antidepressant-like effects of L-theanine in the forced swim and tail suspension tests in mice. Phytother Res 2011; 25: 1636-1639
• 29 Sánchez-Mateo CC, Bonkanka CX, Prado B et al. Antidepressant activity of some Hypericum reflexum L. fil. extracts in the forced swimming test in mice. J Ethnopharmacol 2007; 112: 115-121
• 30 Meyer JH, Ginovart N, Boovariwala A et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 2006; 63: 1209-1216
• 31 Zhong J-M, Wu S-Y, Bai J et al. Antidepressant effect of geranylgeranylacetone in a chronic mild stress model of depression and its possible mechanism. Experimental and Therapeutic Medicine 2012; 4: 627-632
• 32 Mosser DD, Caron AW, Bourget L et al. The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 2000; 20: 7146-7159